Country |
Year |
Age range all adults |
Sample size all adults |
All Males (%) |
All Females (%) |
Total |
Age range young adults |
Sample size young adults |
Young Males |
Young Females (%) |
Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Belgium |
|
2001 |
15-64 |
7347 |
3.6 |
1.8 |
2.7 |
15-34 |
2758 |
8.9 |
3.1 |
5.9 |
Czech Republic |
|
2004 |
18-64 |
3526 |
7.1 |
2.6 |
4.8 |
18-34 |
1414 |
14.2 |
5.4 |
9.8 |
Denmark |
|
2000 |
16-64 |
11825 |
4.5 |
1.3 |
2.8 |
16-34 |
4141 |
9.1 |
2.6 |
5.6 |
Germany |
|
2003 |
18-59 |
8061 |
4.7 |
2.1 |
3.4 |
18-34 |
3775 |
9.9 |
5.2 |
7.6 |
Estonia |
|
2003 |
|
|
2.4 |
0.6 |
1.4 |
|
646 |
5.6 |
1.4 |
3.3 |
Greece |
|
2004 |
15-64 |
4351 |
1.3 |
0.4 |
0.9 |
15-34 |
2620 |
2.1 |
0.9 |
1.5 |
Spain |
|
2003 |
15-64 |
12033 |
11.3 |
3.9 |
7.6 |
15-34 |
5357 |
18.8 |
7.7 |
13.4 |
France |
(1) |
2000 |
15-64 |
11317 |
6.3 |
2.5 |
4.4 |
15-34 |
4749 |
13.2 |
5.3 |
9.3 |
Ireland |
|
2002-03 |
15-64 |
4918 |
3.4 |
1.7 |
2.6 |
15-34 |
|
|
|
4.3 |
Italy |
|
2003 |
15-64 |
11869 |
6.2 |
3.3 |
4.6 |
15-34 |
5231 |
10.9 |
6.7 |
8.6 |
Cyprus |
(2) |
2003 |
15-65 |
1000 |
18.1 |
0.0 |
9.0 |
15-34 |
580 |
23.3 |
0.0 |
12.8 |
Latvia |
|
2003 |
15-64 |
4534 |
3.1 |
0.8 |
1.8 |
15-34 |
|
5.9 |
1.7 |
3.7 |
Lithuania |
|
2004 |
15-64 |
4207 |
1.4 |
0.1 |
0.7 |
15-34 |
1814 |
2.9 |
0.2 |
1.5 |
Hungary |
|
2003 |
18-54 |
|
1.9 |
0.8 |
1.4 |
18-34 |
2319 |
3.8 |
1.6 |
2.8 |
Netherlands |
|
2000-01 |
15-64 |
14045 |
5.1 |
2.2 |
3.7 |
15-34 |
6687 |
9.7 |
4.2 |
7.0 |
Austria |
|
2004 |
15-64 |
3980 |
4.9 |
2.8 |
3.8 |
15-34 |
1754 |
7.6 |
5.2 |
6.4 |
Poland |
|
2002 |
16-64 |
|
2.0 |
0.6 |
1.3 |
16-34 |
|
4.1 |
1.1 |
2.7 |
Portugal |
|
2001 |
15-64 |
14186 |
4.1 |
0.7 |
2.4 |
15-34 |
6406 |
7.4 |
1.4 |
4.4 |
Slovakia |
|
2004 |
15-64 |
1315 |
2.4 |
1.0 |
1.7 |
15-34 |
578 |
4.2 |
2.4 |
3.3 |
Finland |
(3) |
2004 |
15-64 |
2352 |
2.2 |
1.0 |
1.6 |
15-34 |
1031 |
5.9 |
2.4 |
4.0 |
Sweden |
|
2005 |
16-64 |
30538 |
1.1 |
0.5 |
0.8 |
16-34 |
9522 |
2.7 |
0.9 |
1.8 |
United Kingdom (England and Wales) |
|
2004-05 |
16-59 |
28509 |
7.5 |
3.7 |
5.6 |
16-34 |
9913 |
14.1 |
7.2 |
10.6 |
United Kingdom (Northern Ireland) |
|
2002-03 |
15-64 |
3516 |
5.1 |
0.8 |
2.9 |
15-34 |
|
9.2 |
1.7 |
5.4 |
United Kingdom (Scotland) |
|
2003 |
16-64 |
3506 |
6.3 |
2.1 |
4.2 |
16-34 |
1193 |
14.2 |
5.1 |
9.5 |
United Kingdom |
|
2004 |
|
35707 |
8.4 |
4 |
6.2 |
16-34 |
|
15.4 |
7.7 |
11.6 |
Bulgaria |
|
2005 |
18-60 |
1036 |
1.3 |
0.2 |
0.8 |
18-34 |
433 |
3.1 |
0.4 |
1.7 |
Norway |
|
2004 |
15-64 |
2669 |
2.9 |
1.5 |
2.2 |
15-34 |
1238 |
5.3 |
3.6 |
4.5 |
Notes: (1) France: the 2000 surveys was used, instead of the more recent 2002 survey, as this last one did not have information on 'last month prevalence'. (2) Results of this survey should be viewed with caution due to important discrepancies with previous surveys and school surveys results. A new survey with a bigger sample is being conducted in 2005. (3) Finland: Further information on frequency of use in last 30 days collected but not reported due to low numbers of users. For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions. For methods of each survey presented in this table, see Table GPS-1 part (ii). See also 'General notes for interpreting data' on the Explanatory notes and help page. Sources: See Table GPS-0. | ||||||||||||